InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,277.51
(
0.80%
)
US TECH 100
18,064.80
(
0.02%
)
Dow Jones
38,686.32
(
1.51%
)
Brent Oil
81.30
(
0.00%
)
Bitcoin
67,751.40
(
0.40%
)
Post# of 30990
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

knuts4oe

Send PM Follow Ignore
Followers 4
Posts 682
Boards Moderated 0
Alias Born 06/26/2013

knuts4oe

Re: idcc2006 post# 27817

Saturday, 11/05/2016 10:11:53 AM

Saturday, November 05, 2016 10:11:53 AM

Post# of 30990
At the risk of repeating myself, the creditors who have an $85 million claim against any available assets are likely far more determined to squeeze value out of the IP (intellectual property) than beleaguered ex-stockholders. Mullan and co. gave full exposure to anatabine's anti-inflammatory potential, but the media, the markets, and the medical industry paid no attention.

Am hoping we eventually find out why anatabine's seemlngly safe and "novel anti-inflammatory pathway" was not found to be an outstanding medical discovery!!!
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up